NextCure, Inc.·4

Feb 2, 4:17 PM ET

Mayer Timothy 4

4 · NextCure, Inc. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-01-31
Mayer Timothy
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-01-31+131,200131,200 total
    Exercise: $5.57Exp: 2032-01-30Common Stock (131,200 underlying)
Footnotes (1)
  • [F1]One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary